Project Details
Description
Phase IV Randomized Study of Two Dose Levels of Targetin Capsules in Patients with Refractory Cutaneous T-Cell Lymphoma
| Status | Finished |
|---|---|
| Effective start/end date | 3/18/10 → 12/31/20 |
Funding
- EISAI MEDICAL RESEARCH INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.